EP 4330674 A1 20240306 - THE POLARITY AND SPECIFICITY OF SARS-COV2 -SPECIFIC T LYMPHOCYTE RESPONSES AS A BIOMARKER OF DISEASE SUSCEPTIBILITY
Title (en)
THE POLARITY AND SPECIFICITY OF SARS-COV2 -SPECIFIC T LYMPHOCYTE RESPONSES AS A BIOMARKER OF DISEASE SUSCEPTIBILITY
Title (de)
POLARITÄT UND SPEZIFITÄT VON SARS-COV2-SPEZIFISCHEN T-LYMPHOZYTENREAKTIONEN ALS BIOMARKER DER KRANKHEITSSUSZEPTIBILITÄT
Title (fr)
POLARITÉ ET SPÉCIFICITÉ DE RÉPONSES DE LYMPHOCYTES T SPÉCIFIQUES AU SARS-COV2 UTILISÉES EN TANT QUE BIOMARQUEUR DE LA SUSCEPTIBILITÉ AUX MALADIES
Publication
Application
Priority
- EP 21171378 A 20210429
- EP 21171380 A 20210429
- EP 21306369 A 20210930
- EP 2022061635 W 20220429
Abstract (en)
[origin: WO2022229461A1] The application pertains to biomarkers for assessing whether an individual is likely to resist to an infection by a SARS-CoV-2 virus or is susceptible to SARS-CoV-2.
IPC 8 full level
G01N 33/569 (2006.01); A61K 39/00 (2006.01); C07K 14/00 (2006.01)
CPC (source: EP IL)
A61K 39/12 (2013.01 - EP IL); A61P 31/14 (2018.01 - EP IL); C07K 14/005 (2013.01 - EP IL); G01N 33/56972 (2013.01 - EP IL); A61K 2039/572 (2013.01 - EP IL); C12N 2770/20011 (2013.01 - EP IL); C12N 2770/20034 (2013.01 - EP IL); G01N 2333/165 (2013.01 - EP IL); G01N 2333/525 (2013.01 - EP IL); G01N 2333/5406 (2013.01 - EP IL); G01N 2333/5409 (2013.01 - EP IL); G01N 2333/5428 (2013.01 - EP IL); G01N 2333/5437 (2013.01 - EP IL); G01N 2333/55 (2013.01 - EP IL); G01N 2333/57 (2013.01 - EP IL)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
WO 2022229461 A1 20221103; AU 2022266083 A1 20231214; BR 112023022655 A2 20240430; CA 3217132 A1 20221103; EP 4330674 A1 20240306; IL 308102 A 20231201; MX 2023012874 A 20240123
DOCDB simple family (application)
EP 2022061635 W 20220429; AU 2022266083 A 20220429; BR 112023022655 A 20220429; CA 3217132 A 20220429; EP 22726698 A 20220429; IL 30810223 A 20231029; MX 2023012874 A 20220429